What does this research mean for the field?

Non-canonical azole resistance in Aspergillus fumigatus is driven by a highly polygenic network of metabolic, mitochondrial, and regulatory adaptations associated with a distinct population lineage, rather than single target site mutations. Novelty: ClaimNovelty.NOVEL_FINDING. Consensus alignment: ConsensusAlignment.ESTABLISHES_NEW_DIRECTION.

What question did this study set out to answer?

To identify and characterize cyp51A-independent (non-canonical) mechanisms and evolutionary pathways of azole resistance in clinical Aspergillus fumigatus isolates.

August 22, 2026mBioOpen Access

Identification and characterization of non-canonical azole antifungal resistance pathways in Aspergillus fumigatus

View Full Paper

Ask AI

Bookmark

Authors

EDEndrews Delbaje MRMatheus Mertz Ribeiro RBRicardo de Oliveira Barbosa Bitencourt

Discussion

Member takes

Overview

Genomic study uncovers polygenic non-canonical azole resistance in clinical Aspergillus fumigatus, indicating alternative evolutionary routes to antifungal failure.

Key Points

To identify and characterize cyp51A-independent (non-canonical) mechanisms and evolutionary pathways of azole resistance in clinical Aspergillus fumigatus isolates.
Analyzed a global collection of clinical Aspergillus fumigatus isolates lacking canonical cyp51A resistance mutations.
Conducted whole-genome sequencing, population genomics, transcriptomic profiling under azole stress, and functional analyses.
Non-canonical azole resistance strongly correlated with a distinct population lineage across global clinical isolates.
Resistance was driven by a polygenic network involving extensive metabolic remodeling, mitochondrial adaptations, and transcriptional rewiring rather than single target-site mutations.

Cite This Study

Delbaje et al. (2026) studied this question.

synapsesocial.com/papers/6a895f53ca7ade938187dd67 https://doi.org/10.1128/mbio.01723-26

View Full Paper

Ask AI

Bookmark

August 22, 2026mBioOpen Access

Identification and characterization of non-canonical azole antifungal resistance pathways in Aspergillus fumigatus

View Full Paper

Ask AI

Bookmark

Authors

EDEndrews Delbaje MRMatheus Mertz Ribeiro RBRicardo de Oliveira Barbosa Bitencourt

Discussion

Member takes

Overview

Genomic study uncovers polygenic non-canonical azole resistance in clinical Aspergillus fumigatus, indicating alternative evolutionary routes to antifungal failure.

Key Points

To identify and characterize cyp51A-independent (non-canonical) mechanisms and evolutionary pathways of azole resistance in clinical Aspergillus fumigatus isolates.
Analyzed a global collection of clinical Aspergillus fumigatus isolates lacking canonical cyp51A resistance mutations.
Conducted whole-genome sequencing, population genomics, transcriptomic profiling under azole stress, and functional analyses.
Non-canonical azole resistance strongly correlated with a distinct population lineage across global clinical isolates.
Resistance was driven by a polygenic network involving extensive metabolic remodeling, mitochondrial adaptations, and transcriptional rewiring rather than single target-site mutations.

Cite This Study

Delbaje et al. (2026) studied this question.

synapsesocial.com/papers/6a895f53ca7ade938187dd67 https://doi.org/10.1128/mbio.01723-26

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark